Literature DB >> 9129087

Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.

D N Burns1, S Landesman, D J Wright, D Waters, R M Mitchell, A Rubinstein, A Willoughby, J J Goedert.   

Abstract

To assess the relationship between maternal human immunodeficiency virus (HIV) type 1 RNA level, other important covariates, and mother-to-infant (vertical) transmission of HIV-1, third trimester repository specimens from 160 HIV-1-seropositive women enrolled in the Mothers and Infants Cohort Study between 1986 and 1991 were assayed in batch for HIV-1 RNA. A significant association between peripheral blood HIV-1 RNA level and vertical transmission remained after controlling for CD4 cell level, duration of ruptured membranes, "hard" drug (cocaine and heroin) use, and frequency of sexual activity during pregnancy. However, the association was attenuated among women with advanced HIV infection and those with a high frequency of sexual activity during pregnancy. In these settings, interventions that target risk factors other than virus load may be particularly important for preventing vertical transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129087     DOI: 10.1086/593569

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 2.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

3.  Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Authors:  John S Lambert; Jack Moye; Susan F Plaeger; E Richard Stiehm; James Bethel; Lynne M Mofenson; Bonnie Mathieson; Jonathan Kagan; Howard Rosenblatt; Helene Paxton; Hildie Suter; Alan Landay
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  Quantitation of human immunodeficiency virus type 1 in breast milk.

Authors:  M K Ghosh; L Kuhn; J West; K Semrau; D Decker; D M Thea; G M Aldrovandi
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition.

Authors:  Sascha R Ellington; Caroline C King; Athena P Kourtis
Journal:  Future Virol       Date:  2011-11-24       Impact factor: 1.831

6.  Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.

Authors:  M Montano; M Rarick; P Sebastiani; P Brinkmann; M Russell; A Navis; C Wester; I Thior; M Essex
Journal:  Genes Immun       Date:  2006-05-04       Impact factor: 2.676

Review 7.  Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.

Authors:  Omayma Amin; Jenna Powers; Katherine M Bricker; Ann Chahroudi
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

8.  German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

Authors:  Bernd Buchholz; Matthias Beichert; Ulrich Marcus; Thomas Grubert; Andrea Gingelmaier; Annette Haberl; Brigitte Schmied
Journal:  Eur J Med Res       Date:  2009-11-03       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.